Next-Generation Sequencing Tech May Muscle in on SNP Genotyping as 454 s System Hits the Market | GenomeWeb

Roche Applied Science announced last week it has begun selling 454 Life Sciences' Genome Sequencer 20 — the first high-speed, non-Sanger sequencing system to be made commercially available. It may be only a matter of time before next-generation sequencing muscles in on SNP-genotyping in some research and diagnostic applications, but industry observers say that cost and data quality will ultimately be the driving factors in widespread adoption of the new technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.